Acute Ischemic and Hemorrhagic Stroke and COVID-19: Case Series.
Poya FatehiNegin Hesam-ShariatiMorteza AbouzaripourFardin FathiMohammad Bakhtiar Hesam ShariatiPublished in: SN comprehensive clinical medicine (2020)
The coronavirus COVID-19 pandemic is the defining global health crisis of our time and the greatest challenge we have faced since the World Wars; it can attack several systems in the body and has high complications and mortality. COVID-19 can cause venous and arterial thromboembolism due to immobility, high inflammation, extensive intravascular blood coagulation, and hypoxia. In this study, we report 5 cases of adults with COVID-19, hospitalized in Tohid Hospital, Sanandaj, Iran. Three patients were male and two were female. The youngest patient was 20 years old and the oldest was 55 years old. All patients had at least one family member with coronavirus. Fever, chills, muscular pain, cough, and tachypnea were present in all patients. Red blood cell (RBC) was observed in all patients at a low level. Computed tomography (CT) scans of all patients showed abnormal findings in different areas of the brain. These cases indicate that COVID-19 may damage blood vessels in the brain and lead to stroke.
Keyphrases
- sars cov
- computed tomography
- end stage renal disease
- ejection fraction
- newly diagnosed
- coronavirus disease
- chronic kidney disease
- prognostic factors
- healthcare
- type diabetes
- magnetic resonance imaging
- public health
- atrial fibrillation
- risk factors
- coronary artery
- chronic pain
- patient reported outcomes
- spinal cord injury
- magnetic resonance
- global health
- cerebral ischemia
- blood brain barrier
- liver failure
- respiratory syndrome coronavirus
- body composition
- pain management
- endothelial cells
- hepatitis b virus
- cardiovascular events
- brain injury